Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-26 @ 1:18 AM
NCT ID:
NCT04854434
Pre Assignment Details:
A total of 13 participants were enrolled and randomized to receive study treatments Arm A (single-agent selinexor), Arm B (selinexor + pembrolizumab), or Arm C (standard of care) based on the stratification factor of Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 versus 2.
Recruitment Details:
The study was conducted at 3 investigational sites in the United States.
Study:
NCT04854434
Study Brief:
Results Section:
NCT04854434